Linde

Sanjiv Lamba serves as Chief Executive Officer, having assumed the role in March 2022 after previously holding the position of Chief Operating Officer. The modern corporate entity was formed through the 2018 merger of Praxair and Linde AG, a $90 billion deal that produced the world's largest industrial gas company. The merged firm is domiciled in Ireland with principal operational headquarters in Woking, Surrey, and its stock trades primarily on the New York Stock Exchange following the 2023 Frankfurt delisting.

Linde generates revenue through long-term take-or-pay contracts where it builds, owns, and operates gas-production facilities directly on or adjacent to customer sites. Customers—typically refineries, chemical plants, steel mills, and electronics manufacturers—pay recurring fees for the supply of oxygen, nitrogen, hydrogen, and other industrial gases over contract periods typically ranging from 15 to 20 years. This structure produces predictable cash flows tied to client production volumes, a model distinct from the capital-gains-driven returns of private equity or venture capital.

Linde is one of the largest hydrogen producers globally and has publicly committed to expanding its clean-hydrogen capacity, including both blue hydrogen (produced from natural gas with carbon capture) and green hydrogen (produced via electrolysis using renewable power). The company has disclosed several large projects, including a blue-hydrogen facility on the US Gulf Coast tied to ammonia production. Linde views hydrogen mobility and decarbonized industrial heat as long-term growth markets, though its near-term hydrogen revenues remain dominated by refinery and chemical-industry demand (per the firm's public investor materials).

No. Linde is a publicly traded corporation listed on the New York Stock Exchange under the ticker LIN. It is owned by institutional and retail shareholders, not by a single family or founder, and does not manage third-party capital in the manner of a family office, private equity fund, or endowment. Its capital comes from its corporate balance sheet and public equity and debt markets, deployed into industrial plant and infrastructure rather than into financial portfolios or fund commitments.

Linde's end-markets span refining and petrochemicals, steel and metals manufacturing, electronics and semiconductor fabrication, healthcare and medical oxygen, food processing and freezing, and clean energy. Geographically, the company operates across the Americas (including the United States, Canada, Brazil), Europe, the Middle East, Africa, and Asia-Pacific, with significant engineering and operational centers in the US, Germany, India, and China. Its healthcare division supplies medical gases to hospitals in more than 50 countries.

Unlike a private equity platform that acquires companies with the intent to exit within a defined hold period, Linde permanently owns and operates its production and pipeline assets. The firm's value proposition lies in continuous operational integration—its plants often connect directly into customer pipelines for decades—rather than in financial engineering or resale. The 2018 merger made Linde more, not less, of an operating company, as the combined entity pursued cost synergies from integrating two global engineering organizations rather than from leverage or asset flipping.

Linde is a major supplier of medical oxygen, respiratory therapies, and related hospital gases. During the COVID-19 pandemic, the company's medical-oxygen supply chains were classified as critical infrastructure in multiple jurisdictions. While healthcare represents a smaller share of revenue than onsite industrial gas contracts, it provides a steady, counter-cyclical demand base. Linde continues to invest in medical-gas infrastructure and home respiratory services globally, as disclosed in its annual public filings.